Phathom Pharmaceuticals, Inc.·4

Nov 3, 4:54 PM ET

Nabulsi Azmi 4

4 · Phathom Pharmaceuticals, Inc. · Filed Nov 3, 2023

Insider Transaction Report

Form 4
Period: 2023-11-01
Nabulsi Azmi
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2023-11-01+32,500242,067 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    3,578.93
  • Common Stock

    (indirect: By Trust)
    785,700
Footnotes (1)
  • [F1]Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION